![Edward Kaye](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward Kaye
Director/Board Member at
CYTOKINETICS, INCORPORATED
Net worth: 4 M $ as of 2026-05-30
Profile
Dr. Edward M.
Kaye, MD, is a Chief Executive Officer & Director at Aurora Therapeutics, Inc., an Independent Director at Cytokinetics, Inc. and an Advisory Board Member at CureDuchenne Ventures LLC.
He is on the Board of Directors at Aurora Therapeutics, Inc., Stoke Therapeutics, Inc., Cytokinetics, Inc., Massachusetts Biotechnology Council and Convergence Bio, Inc. Dr. Kaye was previously employed as an Independent Director by Avidity Biosciences, Inc., an Independent Director by NeuroVia, Inc., a Group VP-Medical Affairs & Clinical Development by Genzyme Corp., a Chief-Biochemical Genetics by The Children's Hospital of Philadelphia, a Chief-Neurology by St. Christopher's Hospital for Children LLC, and an Associate Professor by Perelman School of Medicine.
He also served on the board at Sarepta Therapeutics, Inc. He received his undergraduate degree from Loyola University New Orleans and a doctorate degree from Stritch School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-02 | 110,874 ( 0.19% ) | 3 M $ | 2026-05-30 | |
| 2026-05-31 | 10,283 ( 0.01% ) | 789 323 $ | 2026-05-30 |
Edward Kaye active positions
| Companies | Position | Start |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Director/Board Member | 2016-05-19 |
| STOKE THERAPEUTICS, INC. | Director/Board Member | 2017-09-30 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Director/Board Member | 2016-02-29 |
CureDuchenne Ventures LLC
 CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements. | Consultant / Advisor | - |
Former positions of Edward Kaye
| Companies | Position | End |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Director/Board Member | 2026-02-26 |
| SAREPTA THERAPEUTICS, INC. | Chief Executive Officer | 2017-06-30 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Chief Tech/Sci/R&D Officer | 2011-05-31 |
The Children's Hospital of Philadelphia
 The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services Operates hospitals | Corporate Officer/Principal | 2000-12-31 |
St. Christopher's Hospital for Children LLC
 St. Christopher's Hospital for Children LLC Medical/Nursing ServicesHealth Services Provides health care services | Corporate Officer/Principal | 1997-12-31 |
Training of Edward Kaye
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Loyola University New Orleans
 Loyola University New Orleans Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
St. Christopher's Hospital for Children LLC
St. Christopher's Hospital for Children LLC Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Perelman School of Medicine
 Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stritch School of Medicine
 Stritch School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services Operates hospitals | Health Services |
NeuroVia, Inc.
 NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule therapeutics for the treatment of neurologic disorders | Health Technology |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements. | Finance |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
- Stock Market
- Insiders
- Edward Kaye
